APA (7th ed.) Citation

L, G., C, R., Y, R., R, J., RL, M., CX, M., . . . EL, M. (2025). Circulating Tumor Cell Dynamics after CDK4/6 Inhibitor for Hormone Receptor-Positive Metastatic Breast Cancer: A Biomarker Analysis from the PACE Phase II Study. Clinical cancer research : an official journal of the American Association for Cancer Research, 31(21), 4510. https://doi.org/10.1158/1078-0432.CCR-25-0327

Chicago Style (17th ed.) Citation

L, Gerratana, et al. "Circulating Tumor Cell Dynamics After CDK4/6 Inhibitor for Hormone Receptor-Positive Metastatic Breast Cancer: A Biomarker Analysis from the PACE Phase II Study." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 31, no. 21 (2025): 4510. https://doi.org/10.1158/1078-0432.CCR-25-0327.

MLA (9th ed.) Citation

L, Gerratana, et al. "Circulating Tumor Cell Dynamics After CDK4/6 Inhibitor for Hormone Receptor-Positive Metastatic Breast Cancer: A Biomarker Analysis from the PACE Phase II Study." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 31, no. 21, 2025, p. 4510, https://doi.org/10.1158/1078-0432.CCR-25-0327.